SHE — Shedir Pharma Srl Unipersonale Cashflow Statement
0.000.00%
- €55.45m
- €52.75m
- €59.39m
- 97
- 81
- 95
- 100
Annual cashflow statement for Shedir Pharma Srl Unipersonale, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 4.91 | 5.31 | 5.7 | 8.24 | 8.08 |
Depreciation | |||||
Non-Cash Items | 0.415 | 0.36 | 0.397 | -0.137 | 0.232 |
Other Non-Cash Items | |||||
Changes in Working Capital | -9.92 | 2.11 | 3.14 | -8.43 | -11.7 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -2.63 | 10 | 11.9 | 2.53 | 0.599 |
Capital Expenditures | -0.469 | -0.461 | -1.23 | -0.427 | -3.61 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 7.02 | -0.505 | -3.6 | -2.34 | -7.58 |
Change in Net Investments | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 6.55 | -0.966 | -4.83 | -2.77 | -11.2 |
Financing Cash Flow Items | -0.363 | -0.195 | -0.212 | -0.234 | -0.313 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -0.772 | 1.25 | -4.41 | -3.07 | -3.94 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 3.15 | 10.3 | 2.64 | -3.3 | -14.5 |